Litcius/Paper detail

Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?

Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa Lynce, Sara M. Tolaney, Ilana Schlam

2024Current Oncology Reports10 citationsDOI

Topics & Concepts

MedicineOncologyTriple-negative breast cancerBreast cancerPembrolizumabChemoimmunotherapyInternal medicineImmunotherapyChemotherapyNeoadjuvant therapyStage (stratigraphy)CancerPaleontologyBiologyCancer Immunotherapy and BiomarkersCancer Cells and MetastasisPARP inhibition in cancer therapy
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better? | Litcius